GENCAP
LIVE

Serial Number

79411807

Owner

Nanjing Genscript Biotech Co., Ltd

Filing Date

Sep 29, 2024

Add to watchlist:

No watchlists yet
View on USPTO

GENCAP Trademark

Serial Number: 79411807

GENCAP is a trademark filed by Nanjing Genscript Biotech Co., Ltd on September 29, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Nanjing Genscript Biotech Co., Ltd (35 trademarks)

No.28 Yongxi Road, Jiangning Science Park,

Entity Type: 99

Trademark Details

Filing Date

September 29, 2024

Registration Date

Not Registered

Goods & Services

Biochemical reagents for medical or veterinary purposes; medicines for the treatment of cardiovascular and cerebrovascular diseases; medicines for the treatment of gastrointestinal diseases; medicines for intestinal disorders; medicines made of chinese traditional medicinal herbs; chemical preparations for pharmaceutical or medical purposes, namely, for the prevention and treatment of cancer, auto-immune diseases, and infectious diseases; nucleic acids for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; reagents for medical use; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; nucleic acid sequences for medical and veterinary purposes; vaccines

Chemical reagents, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; biochemical catalysts; nucleic acids, other than for medical or veterinary purposes; nucleic acid sequences, other than for medical or veterinary purposes; nucleic acids for scientific purposes; diagnostic preparations, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 12, 2026 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 13, 2025 RCCK
REFUSAL PROCESSED BY IB
May 31, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 12, 2025 RFCS
REFUSAL PROCESSED BY MPU
May 12, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 22, 2025 RFCR
SUSPENSION LETTER WRITTEN
Mar 21, 2025 CNSL
ASSIGNED TO EXAMINER
Mar 19, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 30, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 30, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 23, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 12, 2024 REPR